Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 30, 2015 2:56 AM ET

Biotechnology

Company Overview of AmVac AG

Company Overview

AmVac AG develops vaccines for the treatment and prevention of widespread infections and urogenital conditions. The company offers Gynevac, a platform for the treatment of urogenital conditions; MALP platform that enables the generation of a new class of vaccine adjuvants, which are mixed with vaccines to increase their efficacy; and Sendai, a virus vector platform that enables the generation of a new class of ‘semi-live’ vaccines for the prevention of respiratory syncytial virus infections. It also offers vaccines for the prevention of seasonal and pandemic influenza, chronic prostatitis, and benign prostate hyperplasia; and acute, subacute, and chronic gynecological inflammations. AmVac AG...

Metallstraße 4

Zug,  6300

Switzerland

Founded in 2005

Phone:

41 41 725 32 30

Fax:

41 41 725 32 39

Key Executives for AmVac AG

Chief Executive Officer
Chairman of The Supervisory Board, Chief Legal Officer and Head of Operations
Founder and Member of Supervisory Board
Chief Operating Officer
Head of Research & Development
Compensation as of Fiscal Year 2014.

AmVac AG Key Developments

AmVac AG Announces Management Changes

The Board of Directors of AmVac AG has appointed Ali Pashazadeh with immediate effect as Chief Executive Officer of the company. After transferring her operating management responsibilities to Ali Pashazadeh, company founder Melinda Karpati will focus on chairing the Scientific Committee of the AmVac Board of Directors.

Similar Private Companies By Industry

Company Name Region
Genkyotex S.A. Europe
BOWS Pharmaceuticals AG Europe
Innomedica Holding AG Europe
Rapid Pharmaceuticals AG Europe
Metabomed Ltd. Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AmVac AG, please visit amvac.eu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.